🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single arm, multicenter phase II trial for 60 patients with untre...
Status
Terminated
Location
City of Hope
Start Date
2021-01-05
Trial ID
NCT04610684
Treatments Being Tested
Etoposide-cisplatin/ -carboplatin in combination with PD-L1 inhibitor for 4...
Status
Completed
Location
Hunan cancer hospital
Start Date
2020-06-01
Trial ID
NCT04636762
Treatments Being Tested
This is a single arm, Phase II trial involving the use of atezolizumab plus...
Status
Recruiting
Location
Johns Hopkins University: Sibley Memorial Hospital
Start Date
2022-06-27
Trial ID
NCT05312671
Treatments Being Tested
This is a single-arm Phase Ib/II multicenter open-label study, with transla...
Status
Completed
Location
ICO Badalona
Start Date
2021-03-17
Trial ID
NCT04487756
Treatments Being Tested
This phase III trial studies how well chemotherapy and radiation therapy (c...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-07-26
Trial ID
NCT03811002
An open-label, multicenter phase Ib/II clinical study to evaluate the safet...
Status
Recruiting
Location
Anhui Provincial Hospital
Start Date
2023-12-08
Trial ID
NCT06157827
This is a randomized, open-label study of Serplulimab plus chemotherapy (Ca...
Status
Active Not Recruiting
Location
Alabama Oncology
Start Date
2022-11-18
Trial ID
NCT05468489
A study consisting of a dose-escalation phase and a dose-expansion phase to...
Status
Terminated
Location
Emory University
Start Date
2020-09-22
Trial ID
NCT04422210
Treatments Being Tested
This is a first-in-human, Phase 1/2, open-label, dose escalation, dose expa...
Status
Recruiting
Location
City of Hope (City of Hope National Medical Center, City of Hope Medical Center)
Start Date
2023-09-05
Trial ID
NCT05652686
This Phase II study was designed to evaluate the safety and efficacy of Ate...
Status
Unknown
Location
Shanghai Pulmonary Hospital
Start Date
2021-01
Trial ID
NCT04696939
Treatments Being Tested